Literature DB >> 19250386

A molecular approach for identifying individuals with Li-Fraumeni syndrome who have a limited family history.

P Ang, I H K Lim, R Y Y Yong, A S G Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19250386     DOI： 10.1111/j.1399-0004.2008.01133.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN： 0009-9163            Impact factor:   4.438


× No keyword cloud information.
  2 in total

1.  TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort.

Authors:  J J Bakhuizen; F B Hogervorst; M E Velthuizen; M W Ruijs; K van Engelen; T A van Os; J J Gille; M Collée; A M van den Ouweland; C J van Asperen; C M Kets; A R Mensenkamp; E M Leter; M J Blok; M M de Jong; M G Ausems
Journal:  Fam Cancer       Date:  2019-04       Impact factor: 2.375

2.  Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.

Authors:  Daphne S C Lee; Sook-Yee Yoon; Lai Meng Looi; Peter Kang; In Nee Kang; Kavitta Sivanandan; Hany Ariffin; Meow Keong Thong; Kin Fah Chin; Nur Aishah Mohd Taib; Cheng-Har Yip; Soo-Hwang Teo
Journal:  Breast Cancer Res       Date:  2012-04-16       Impact factor: 6.466
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.